Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01766271
Other study ID # Pro00029973
Secondary ID
Status Completed
Phase N/A
First received October 15, 2012
Last updated November 6, 2014
Start date October 2012
Est. completion date October 2014

Study information

Verified date November 2014
Source Duke University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this 4 group (2x2) pilot randomized controlled trial is to test the feasibility and logistics of incorporating genetic risk information (9p21)into standard Coronary Heart Disease (CHD) risk counseling or health coaching intervention (or both) in primary care at 2 Duke Clinics.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date October 2014
Est. primary completion date May 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age 18+,

- presence of at least one of the following:

- FPG > 100,

- HbA1c > 5.7%,

- diabetic,

- LDL > 129,

- triglycerides > 150,

- total cholesterol > 200,

- SBP > 130,

- BMI > 25,

- able to speak and understand English,

- able and willing to give informed consent

Exclusion Criteria:

- diagnosed CHD (MI or documented coronary artery disease),

- inability to ambulate or participate in physical activity,

- serious chronic disease related complications,

- current participation in a risk communication study for chronic disease,

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Intervention

Behavioral:
Health Coaching
biweekly health coaching for 5 months
Genetic:
9p21
Genetic testing results of 9p21
Other:
Standard Risk Assessment
All 4 arms are assigned to receive standard assessment on coronary heart disease risk

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Outcome

Type Measure Description Time frame Safety issue
Primary Diet National Cancer Institute (NCI) Multifactor Screener 6 months No
Primary Physical Activity Stanford Brief Activity Scale (SBAS) 6 months No
Secondary Fasting blood glucose 6 months Yes
Secondary Systolic blood pressure 6 months No
Secondary Body mass index 6 months No
Secondary Waist circumference 6 months No
Secondary Low Density Cholesterol (LDL) 6 months No
Secondary Triglyceride 6 months No
Secondary Total cholesterol 6 months No
See also
  Status Clinical Trial Phase
Recruiting NCT01542086 - Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease N/A